A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.

Why Quality Standards of Drugs has to be the Primary Focus Area for Pharmaceutical Industry

Time and again Indian pharmaceutical industry has faced concerns due to its manufacturing standards and quality which have led to penalties and drops in export figures For the industry to realise its potential to capture world markets the primary focus has to be towards improving quality standards t..


How China is investing in its pharmaceutical market

The nuances of clinical and regulatory product development in China and its similarities and contrasting aspects in comparison to the rest of the world are discussed in this article The specifics within risk management and the global regulatory authorities that contribute to this complex landscape w..

Advancing Production Capabilities to Boost China’s Pharmaceutical Market

The path forward is paved with Industry 4.0 and brand security solutions alongside regulatory change and new infrastructure

According to 2017s report by the US Chamber of Commerce on the Made in China 2025 industrial plan an innovation gap leaves the country dependent on foreign companies for patented pharmaceutical drugs As China aims to close that gap companies must advance packaging operations to scale production with..

Integrated Drug Development Strategy

The nexus to value-based pricing

With only 12 per cent of drug candidates entering clinical trials resulting in an approved drug and 20 per cent recouping their investment there is an unquestionable need to change the way pharma develops drugs This paper will show how a modern stateoftheart integrated drug development strategy uses..

Statin Drug Interactions and Related Adverse Reactions

Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting combinations are ..

The Evolution of Brand Strategy

As the pharmaceutical market transforms, so does the meaning of brand strategy

The basic structure of brand strategy evolved decades ago and has barely changed since Its key componentsclinical indication advantages and communication methodsare relics of a time when professionals prescribed on the basis of clinical claims and little else mattered But as our market has evolved i..

The Importance of Post-Hire Screening in the Pharmaceutical Industry

Preemployment background checks are generally wellaccepted as part of the hiring process in highlyregulated sectors such as the pharmaceutical industry But what happens posthire once a new employee is onboard and welcomed into the company While many aspects of a preemployment background check are st..

Biosimilars Interchangeability

Regional views aren’t interchangeable

With many biosimilars reaching the market interchangeabilitysubstitution with the reference product has become a hot topic The FDA has released draft guidance on this topic requiring specific and quite complex study designs to demonstrate interchangeability that raised several comments from all type..

Setting up a Pharmacovigilance System

Pharmacovigilance is a complex process for which robust systems are essential A strong PV system is an important part of the overall medicinal product Regulatory system It reflects on the stringency and competence of the Regulatory bodies in regulating the market and ensuring the safety and effectiv..

Future Prospects of Biotherapeutics and Challenges

Advancements in the biotechnology have presented pharmaceutical manufacturing industries biotherapeutics which are promising as potential future therapeutics Diverse categories of biotherapeutics are coming into the market which range from monoclonal antibodies growth hormones and cytokines to vacci..